-

U.S. Weight Loss & Diet Control Market Report 2021: Market Reached a Record $78 Billion in 2019, but Suffered a 21% Decline in 2020 Due to COVID-19 - Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The U.S. Weight Loss & Diet Control Market" report has been added to ResearchAndMarkets.com's offering.

The U.S. weight loss market reached a record $78 billion in 2019, but suffered a 21% decline in value during 2020 due to the Covid-19 pandemic and recession.

However, there were bright spots. Commercial chains held up well, as did the meal replacements market, frozen diet entrees, and multi-level marketing channels. Health clubs and most medical weight loss programs were hit the hardest, with contractions of 37% and 27%, respectively. Weight loss providers had to pivot to virtual client meetings and drop shipping of products.

Technology became more important, as Zoom meetings, apps and streaming services soared in usage. Due to pend-up demand and consumer weight gain in 2020, most providers are looking for a strong rebound in 2021, as Americans are vaccinated and businesses reopen.

Do-it-yourself plans still abound as consumers use free diet & fitness apps. Many untapped niches still exist. This is a completely revised and updated analysis of the publisher's best-selling biennial study about the U.S. weight loss market. This is the most comprehensive investigation of the U.S. weight loss market published by anyone worldwide.

Covered: dollar value & growth rates of all major weight loss market segments (early 1980s to 2019, 2020, 2021 and 2025 forecasts), latest market trends and developments, status reports for:

Diet soft drinks, artificial sweeteners, health clubs, commercial diet center chains, multi-level marketing diet plans, retail meal replacements & diet pills, medical programs (weight loss surgery, MDs, hospitals/clinic programs, Rx diet drugs, bariatricians, VLCD programs), low-cal frozen entrees, and the diet books & exercise DVDs market.

New for this edition:

  • Effects of the Pandemic on operations/revenues for all market segments
  • How dieter behavior changed with the pandemic
  • 2021 & 2025 Forecasts
  • The most popular diets like Keto, intermittent fasting
  • Leading competitor top management interviews
  • How the 2021 diet season is shaping up
  • Why MLM has gained as a distribution model
  • Why meal replacements are still strong, but not retail diet pills.
  • Outlook for medical weight loss programs of all types, why they've lost momentum

Also included:

32-year revenue analysis of the market through past recessions and fad diet cycles, comprehensive dieter demographics, weight loss center franchising, and extensive national/state commercial centers' operating ratios. Rankings & revenues of top commercial chains, brand sales, and a Reference Directory.

Key Topics Covered:

  1. Introduction, Scope, Methodology
  2. Executive Overview
  3. Dieter Demographics
  4. American Exercise Trends & The Health Clubs Industry
  5. Commercial Weight Loss Chains
  6. Industry Structure & Key Ratios
  7. The Diet Soft Drinks & Artificial Sweeteners & Diet Food Markets
  8. The Artificial Sweeteners Market
  9. Retail Meal Replacements & Appetite Suppressants Market
  10. Medically-Supervised Weight Loss Programs
  11. Bariatrician (Obesity Medicine Specialists) Programs
  12. The Weight Loss (bariatric) Surgery Market
  13. VLCD/LCD Fasting Supplement Programs
  14. The Diet Drugs Market
  15. The Diet Books & Exercise DVDs Market

Companies Mentioned

  • Atkins Nutritionals
  • BeachBody
  • Centers for Medical Weight Loss
  • Dr. G's
  • Herbalife
  • HMR
  • Ideal Protein
  • Isagenix
  • Jenny Craig
  • JumptStart MD
  • Lindora Clinics
  • Medi-Weightloss
  • Medifast
  • Metabolic Research
  • Noom
  • NutriSystem
  • Nuviva
  • Optifast
  • Profile by Sanford
  • Robard
  • Slim-Fast
  • Slimgenics
  • Smart For Life
  • Visalus
  • Weight Watchers

For more information about this report visit https://www.researchandmarkets.com/r/4zamb2

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Platinum-Based Catalysts Market Outlook to 2029 & 2034: Revenues to Reach $4.98 Billion by 2029 - Industry Leaders are Sinopec Catalyst Co., BASF, Thermo Fisher Scientific, and Linde - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Platinum-Based Catalysts Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The platinum-based catalysts market has experienced robust growth recently, with its value expected to expand from $3.67 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. This previous growth is primarily driven by the automotive industry's demand, stricter environmental regulations, fuel cell technology adoption, and the...

Middle East Colocation Data Center Portfolio Analysis Report 2025: Khazna Data Centers, Saudi Telecom Company and Gulf Data Hub Rank Among the Leading Data Center Operators by Capacity - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Middle East Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Middle East hosts around 170+ existing data centers, with countries like the UAE & Saudi Arabia having a strong presence in the region. Khazna Data Centers, Saudi Telecom Company and Gulf Data Hub rank among the leading data center operators by capacity across Middle East. The United Arab Emirates dominates the existing market with a power ca...

CD22 Targeted Therapies Market Research Report 2025-2026: Approved Drug Sales, Technology Platforms & Clinical Trials Insights - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CD22 Targeted Therapies Market, Approved Drug Sales, Technology Platforms & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Current & Future Global Market Outlook Insight on CD22 Targeted Approaches Approved Drug Dosage, Price & Sales Insight CD22 Targeted Therapies Development Trends by Region & Indications CD22 Targeted Therapies in Clinical Trials: > 20 Therapies CD22...
Back to Newsroom